04/29/2024 | Press release | Distributed by Public on 04/29/2024 08:20
Item 5.07 Submission of Matters to a Vote of Security Holders | ||||
(a) The Pfizer Inc. (the "Company") Annual Meeting of Shareholders was held on April 25, 2024. | ||||
(b) Shareholders voted on the matters set forth below. | ||||
1. The nominees for election to the Company's Board of Directors set forth in Item 1 to the Company's Proxy Statement filed with the U.S. Securities and Exchange Commission on March 14, 2024 were elected to hold office until the Company's next Annual Meeting of Shareholders, based upon the following votes: | ||||
Nominee
|
Votes For
|
Votes Against
|
Abstentions
|
Broker non-vote
|
Ronald E. Blaylock | 3,611,209,480 | 74,828,190 | 16,147,043 | 893,428,132 |
Albert Bourla | 3,416,127,786 | 272,930,253 | 13,129,674 | 893,428,132 |
Susan Desmond-Hellmann | 3,609,882,463 | 76,819,517 | 15,485,733 | 893,428,132 |
Joseph J. Echevarria | 3,534,360,661 | 151,136,693 | 16,687,322 | 893,428,132 |
Scott Gottlieb | 3,641,520,694 | 46,699,897 | 13,967,122 | 893,428,132 |
Helen H. Hobbs | 3,559,147,586 | 127,638,461 | 15,401,666 | 893,428,132 |
Susan Hockfield | 3,640,156,517 | 46,187,757 | 15,843,439 | 893,428,132 |
Dan R. Littman | 3,602,649,863 | 83,205,522 | 16,332,328 | 893,428,132 |
Shantanu Narayen | 3,624,752,522 | 61,360,816 | 16,074,375 | 893,428,132 |
Suzanne Nora Johnson | 3,509,903,128 | 174,627,508 | 17,657,077 | 893,428,132 |
James Quincey | 3,608,797,590 | 76,444,804 | 16,945,319 | 893,428,132 |
James C. Smith | 3,566,491,624 | 117,466,325 | 18,229,764 | 893,428,132 |
2. The proposal to ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the 2024 fiscal year was approved based upon the following votes:
|
|
Votes for approval
|
4,315,675,552 |
Votes against
|
256,738,678 |
Abstentions
|
23,201,615 |
Broker non-votes
|
n/a
|
3. The proposal to approve the Amended and Restated Pfizer Inc. 2019 Stock Plan was approved based upon the following votes:
|
|
Votes for approval
|
3,405,629,196 |
Votes against
|
275,998,451 |
Abstentions
|
20,560,066 |
Broker non-votes
|
893,428,132 |
4. The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers was approved based upon the following votes:
|
|
Votes for approval
|
3,360,637,251 |
Votes against
|
315,293,726 |
Abstentions
|
26,256,736 |
Broker non-votes
|
893,428,132 |
5. The shareholder proposal to Adopt an Independent Board Chair Policy was not approved based upon the following votes: | |
Votes for approval
|
1,284,408,190 |
Votes against
|
2,391,266,871 |
Abstentions
|
26,511,479 |
Broker non-votes
|
893,428,132 |
6. The shareholder proposal to Publish a Congruency Report on Political, Lobbying, Electioneering Expenditures was not approved based upon the following votes:
|
|
Votes for approval
|
515,502,691 |
Votes against
|
3,123,669,364 |
Abstentions
|
63,015,226 |
Broker non-votes
|
893,428,132 |
7. The shareholder proposal to Amend the Director Resignation Process was withdrawn by the proponent and not presented at the Annual Meeting.
|
|
8. The shareholder proposal to Publish a Report on Corporate Contributions was not approved based upon the following votes:
|
|
Votes for approval | 137,986,751 |
Votes against
|
3,505,075,475 |
Abstentions
|
59,125,487 |
Broker non-votes
|
893,428,132 |